SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-250822
Filing Date
2023-10-04
Accepted
2023-10-04 17:21:58
Documents
12
Period of Report
2023-10-04
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d537542d8k.htm   iXBRL 8-K 24626
  Complete submission text file 0001193125-23-250822.txt   142331

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alxo-20231004.xsd EX-101.SCH 2863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20231004_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20231004_pre.xml EX-101.PRE 10821
6 EXTRACTED XBRL INSTANCE DOCUMENT d537542d8k_htm.xml XML 3290
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 231308966
SIC: 2834 Pharmaceutical Preparations